Bacteria often coordinate virulence factors to fine-tune the host response during infection. These coordinated events can include toxins counteracting or amplifying effects of another toxin or though regulating the stability of virulence factors to remove their function once it is no longer needed. Multifunctional autoprocessing repeats-in toxin (MARTX) toxins are effector delivery toxins that form a pore into the plasma membrane of a eukaryotic cell to deliver multiple effector proteins into the cytosol of the target cell. The function of these proteins includes manipulating actin cytoskeletal dynamics, regulating signal transduction pathways and inhibiting host secretory pathways. Investigations into the molecular mechanisms of these effector domains are providing insight into how the function of some effectors overlap and regulate one another during infection. Coordinated crosstalk of effector function suggests that MARTX toxins are not simply a sum of all their parts. Instead, modulation of cell function by effector domains may depend on which other effector domain are co-delivered. Future studies will elucidate how these effectors interact with each other to modulate the bacterial host interaction.
Introduction
Bacteria utilize an arsenal of secreted virulence factors to alter host cells to promote bacterial survival and dissemination, thereby enhancing disease. While many of these factors operate independently of one another, bacteria can also coordinate the expression, secretion, function and stability of these proteins to synergize effects or offset negative effects during infection. For example, uropathogenic Escherichia coli (UPEC) simultaneously produces and secretes two toxins -ahemolysin (HlyA) and cytotoxic necrotizing factor 1 (CNF1) from the same operon (Landraud et al., 2003; Diabate et al., 2015) . CNF1 constitutively activates members of the Rho GTPases, which are a family of proteins that regulate multiple signaling pathways including actin cytoskeleton dynamics (Bokoch, 2005; Lemonnier et al., 2007) . Although CNF1 promotes infection, activation of Rho GTPases leads to the upregulation of pro-inflammatory cytokines and increased host mortality. However, CNF1 mediated activation of the innate immune response is inhibited by the coordinately expressed pore-forming toxin HlyA. Thus, UPEC coordinates expression of the two secreted toxins to fine-tune the host response to regulate infection (Diabate et al., 2015) .
Similarly, Salmonella enterica serovar Typhimurium (S. typhimurium) delivers multiple effector proteins to host cells using Type III secretion systems (T3SS) (Coburn et al., 2007) . The first T3SS (T3SS1) secretes effectors to promote uptake of the bacteria into nonphagocytic cells (Lostroh and Lee, 2001) . This is achieved in part by the effector SopE, which is a guanine nucleotide exchange factor (GEF) mimic that activates Rho GTPases (Humphreys et al., 2012) . Activation of Rho GTPases induces actin polymerization for membrane ruffling to engulf the bacteria and allow for invasion into the cell (Humphreys et al., 2012; Popoff, 2014) . However, in addition to SopE, S. typhimurium T3SS1 secretes other effectors including SptP. SptP is a GTPase activating protein (GAP) mimic that induces Rho GTP hydrolysis and leaves the GTPase in its inactive form (Fu and Galan, 1999) . SopE is quickly degraded by the proteasome following bacterial invasion, allowing SptP to reverse SopE activation of Rho family GTPases to restore host membrane architecture (Kubori and Galan, 2003) . By designing SopE to be more vulnerable to host degradation, S. typhimurium can coordinate its effector proteins to reverse the function of a previous effector once that function is no longer needed. Additional beneficial interactions between S. typhimurium effectors has been identified and these collectively are referred to as binary entry effector interplay (or BENEFIT) (Cain et al., 2008) .
Multifunctional-autoprocessing repeats-in toxin (MARTX) toxins are large secreted proteins that are a unique hybrid of secreted toxins and multi-effector delivery systems. Similar to many bacterial protein toxins, MARTX toxins form a pore in the host cell plasma membrane to translocate multiple cis-carried effector domains into the target cell cytosol. However, distinct from single function toxins that direct just one effector domain into cells, MARTX toxins have been found to carry up to 5 effector domains, simultaneously delivering a bolus of enzymatic potential into the cells. While many previous studies have focused on the mechanisms of individual effector domains, little is known about how these effector activities are coordinated to interact together during infection. Furthermore, the collection of effector domains drawn from 10 known effectors can vary among species, and even within different strains of the same species . Hence, the large number of combinations of MARTX toxin effector domains could allow bacteria to coordinate virulence by a plethora of mechanisms. Furthermore, toxin effector interplay could vary with each MARTX toxin variant. As the mechanism of action of independent effectors become better understood, exploring MARTX effector crosstalk during infection can provide further insight about how bacteria regulate the host environment to promote infection.
MARTX toxins
Genes encoding MARTX toxins have been identified in many genera of Gram-negative bacteria including, Vibrio, Aeromonas, Proteus, Photorhabdus and Xenorhabdus. In all cases, the MARTX toxins and their associated secretion systems are encoded on two operons. The operon rtxHCA encodes the structural toxin RtxA (or sometimes RtxA1) along with a putative acyltransferase RtxC, and a conserved hypothetical protein RtxH. The operon rtxBDE encodes the MARTX toxin associated atypical Type 1 secretion system (Boardman and Satchell, 2004; Lee et al., 2008b; Satchell, 2011; Gavin and Satchell, 2015; Satchell, 2015) .
The structural rtxA genes are often the largest genes of the bacterium as MARTX toxins can range from 3500 to 5300 amino acids (aa) in length. The N-and Ctermini of the toxins contain repeat sequences that are conserved across all MARTX toxins (Fig. 1) . The C-terminal non-canonical RTX repeat sequences categorize MARTX toxins within the larger RTX family of proteins (Lin et al., 1999; Satchell, 2011; Satchell, 2015) . These are predicted to bind Ca 21 ions to stabilize the negative charge from the aspartate to form b-barrels that are essential for a ratchet mechanism of secretion (Bumba et al., 2016) . Indeed, the C-terminal repeats and calcium in the media were both found to be essential for MARTX toxin Type I secretion (Kim et al., 2015; Chen et al., 2017) , which results in a loss of bacterial cytotoxic activity (Kim et al., 2013) . The N-terminal arm has also been shown to be essential for toxin activity in tissue culture (Kim et al., 2015) , possibly by organizing to form a translocation pore in the eukaryotic cell plasma membrane that is estimated at 1.63 nm (Kim et al., 2008) . How the repeat regions from this hypothetical pore is not yet known, but structural modeling suggests the N-terminal repeats form a b-barrel structure with alternating hydrophobic and charged turns. Conceptually, this could create an exposed hydrophobic surface that could potentially organize in threedimensions to generate a hydrophilic pore with hydrophobic side facing the lipid bilayer (Fig. 2) .
In between the N-and C-terminal arms lies the variable effector domain region and a conserved autoprocessing cysteine protease domain (CPD) . This region has low thermodynamic The N-and C-terminus consist of conserved glycine rich A and B repeats and glycine-aspartate rich C-repeats. These repeat regions flank the variable effector domain region along with a conserved cysteine protease domain. The number of effector domains can vary depending the bacterial species and strain. Additionally, a type I secretion signal (T1S.S.) is located at the extreme end of the C-terminus and is required for toxin secretion from the bacterial cytosol. stability, which is suggested to enhance unfolding and promote both effector protein and CPD translocation through the narrow pore formed by the repeat regions (Kudryashova et al., 2014) . Following translocation, cytosolic inositol hexakisphosphate activates the CPD to release the effector domains to the cell by autoprocessing (Prochazkova et al., 2009; Egerer et al., 2010) .
MARTX toxin effector domains
The number and diversity of effector domains on an individual MARTX toxin can vary between strains of bacteria. Almost all known rtxA1 strains of V. cholerae carry the same three effector domains (Dolores and Satchell, 2013) . By contrast, other bacterial species encode MARTX toxins that carry up to 5 of 10 total identified effector domains as part of their domain repertoire and the organization of the effectors can vary by strain (Ziolo et al., 2014; Satchell, 2015) . The function of these domains can fall into three categories: regulation of the actin cytoskeleton, manipulation of host signaling and cell death pathways and inhibition of autophagy and secretory pathways.
Regulation of cytoskeleton
The actin cross-linking effector domain (ACD) directly catalyzes the formation of an iso-peptide bond between residue E270 on one G-actin monomer to the K50 residue on another actin monomer. Repetitive addition of monomers results in actin dimers, trimers and higher multimers, ultimately driving disassembly of actin stress fibers (Cordero et al., 2006; Kudryashov et al., 2008b) . Structural prediction of ACD and the later solved structure of the ACD of Type 6 secretion effector VgrG1 revealed ACD has similarities to glutamine synthases with a conserved organization of their active sites (Geissler et al., 2009; Durand et al., 2012) . These studies suggest a catalytic mechanism in which ACD utilizes a glutamic acid residue to coordinate actin, Mg 21 and ATP and then transfer the g-phosphate from the ATP to residues E270 on one actin monomer, which then activates its ligation to the K50 residue of another actin monomer (Geissler et al., 2009; Durand et al., 2012; Kudryashova et al., 2012; Kudryashova et al., 2017) . The subsequent ACD-mediated disassembly of the actin cytoskeleton is sufficient to disrupt tight junctions of polarized T84 cell monolayers and inhibit macrophage phagocytosis in vitro (Dolores et al., 2015) . However, these effects on cytoskeleton integrity can occur far ahead of total cross-linking of cellular actin. In fact, the cross-linked actin dimers form early in the cross-linking process themselves can act as secondary toxins by sequestering and inhibiting formins, which are required for actin polymerization and other host cell functions (Heisler et al., 2015; Kudryashova et al., 2017) . In addition to directly targeting actin, MARTX toxin effector domains can indirectly affect cytoskeleton assembly. The Rho-inactivation domain (RID) induces actin depolymerization by inactivating the Rho family GTPases, with substrate preference for Rac1 Ahrens et al., 2013; Dolores et al., 2015; Zhou et al., 2017) . RID is an N E -fatty acyltransferase that adds a fatty acid to the C-terminal polybasic region of Rho GTPases. This modification inhibits guanine exchange factor activation and prevents Rho GTPases from interacting with their downstream effectors (Zhou et al., 2017) . RID inactivation of Rho GTPases is sufficient to cause cell rounding (Ahrens et al., 2013) and to disrupt the integrity of polarized T84 cell monolayers, however unlike ACD, RID poorly inhibits macrophage phagocytosis (Dolores et al., 2015) . The The N-terminal B-repeats from V. vulnificus MARTX toxin aa 655-854 are predicted to form a b-barrel that contains hydrophobic and charged turns along with an exposed hydrophobic surface that could hypothetically interact with the eukaryotic plasma membrane.
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protein also contributes to inactivation of cell signaling through focal adhesion and p21-activated kinases (Chen et al., 2017; Zhou et al., 2017) . Genetic analysis revealed that RID is divided into two subdomains: the membrane localization subdomain (MLD) that presents a basic-hydrophobic motif for binding to anionic lipids at the plasma membrane (Geissler et al., 2010; Geissler et al., 2012) and an activity subdomain that contains a His-Asp-Cys catalytic triad (Ahrens et al., 2013) . Structural analysis confirmed the RID subdomain organization and revealed RID has a twisted U-shape structure that is divided into two nodes. The N-terminal node contains the helical MLD. The C-terminal activity subdomain has a permuted papain-like core structure and is similar to the human fatty acid acyltransferase HRas-like tumor suppressor 3 (HRASLS3) (Pei and Grishin, 2009; Zhou et al., 2017) . This subdomain also has high binding affinity to the acyltransferase substrate palmitoyl-CoA, which is abundant in the eukaryotic cell cytosol (Zhou et al., 2017) .
Manipulation of host signaling and cell death pathways
Eukaryotic cells utilize various receptors to detect pathogen associated molecular patterns (PAMPs) and then transmit these 'danger' signals through, among others, the ERK, p38 and JNK MAPK pathways to promote expression of pro-inflammatory cytokines and mount and immune response (Shim et al., 2005; Arthur and Ley, 2013) . Therefore, many bacterial pathogens have developed tools to suppress these host defenses (Li et al., 2007; Paquette et al., 2012; Reddick and Alto, 2014) . The Ras/Rap1 specific endopeptidase (RRSP) MARTX effector domain suppresses the ERK MAPK pathway by proteolytically processing Ras and Rap1 GTPases in the Switch 1 between the Y32 and D33 residues (Antic et al., 2015; Biancucci et al., 2017) . This processing then prevents Ras from activating ERK and inhibits cell proliferation (Antic et al., 2015) .
MARTX toxin effectors can also alter cell signaling by manipulating levels of cyclic-AMP, a secondary signaling molecule that can regulate signal transduction pathways to modulate the production of pro-inflammatory cytokines or disrupt cell ion homeostasis (Aronoff et al., 2006; McDonough and Rodriguez, 2011) . The ExoY-like MARTX effector domain is an adenylate cyclase that was identified due to its homology to the Pseudomonas aeruginosa T3SS effector ExoY (Ziolo et al., 2014) . The ExoY-like domain was shown to have adenylate cyclase, but not guanylate cyclase activity (Ziolo et al., 2014) , and also to bind to actin, which significantly increases its enzymatic activity (Belyy et al., 2016) .
Along with altering host cell signaling, MARTX toxins have also been identified as activators of cell death signaling pathways in human epithelial cells (Lee et al., 2008a) . The makes caterpillars floppy (MCF)-like domain is a prevalent effector domain that undergoes Nterminal autoprocessing when either expressed in HeLa cells or when purified MCF is treated with host cell lysate (Agarwal et al., 2015a) . The activation of cell death depends on N-terminal autoprocessing that requires an unusual Arg-Cys-Asp (RCD) putative active site (Agarwal et al., 2015a; Agarwal et al., 2015c) . These data suggest a partial mechanism in which, following toxin mediated translocation, host cellular factors induce pro-MCF autoprocessing to activate its cytopathic activity. The mechanism of cell death is linked to MCFinduced depolarization of the mitochondrial membrane potential, which causes the damaged organelle to release cytochrome c into the cytosol. This release leads to the upregulation of pro-apoptotic factors Bax and Bak, caspase and PARP-g activation and eventually cell death (Agarwal et al., 2015c) . The target and the biochemical mechanism by which MCF induces mitochondrial-mediated apoptosis is still under investigation. While treatment of cells with a pan-caspase inhibitor prior to MCF intoxication inhibit effector induced apoptosis, the intoxicated cells still show significant rounding (Agarwal et al., 2015c) . This suggests that MCF does not directly activate caspase-mediated apoptosis, but rather induction of cell death might be a downstream event of the effector function.
Inhibition of autophagy and secretory pathways
While signal transduction cascades directly transmit PAMP-induced danger signals, propagation of these signals can be enhanced by the activation of autophagy. Autophagy can promote activation of innate immune signals by delivering PAMPs to cytosolic receptors and enhance transmittance of MAPK signals by utilizing autophagosomes as scaffolds for signal transduction proteins (Deretic et al., 2013; Martinez-Lopez et al., 2013) . ABH is a phospholipase A1 that is highly specific for phosphatidylinositol-3-phosphate (PI3P) (Agarwal et al., 2015b) . PI3P promotes autophagosome formation and ABH-mediated depletion of the molecule leads to inhibition of autophagy and endosomal trafficking (Schink et al., 2013; Agarwal et al., 2015b) . In addition, as defects in autophagy can impair secretory pathways, ABH might be able to suppress the secretion of proinflammatory cytokines. In a separate study, ABH was shown to activate CDC42 (Dolores et al., 2015) . Phosphoinositides like PI3P have been identified as signaling molecules of Rho family GTPases, suggesting that ABH mediated depletion of PI3P may alter host lipid homeostasis to indirectly regulate GTPase activity (Payrastre et al., 2001) . Therefore, ABH may place a multifaceted role during infection where it changes lipid dynamics to alter both autophagy and other host signal transduction pathways.
MARTX toxin effector domains also target secretory pathways independently of autophagy. Domain X (DmX) is a MARTX toxin effector domain with a Cys-His-Asp catalytic triad to undergo N-terminal autoprocessing and induce Golgi fragmentation. This leads to cytopathic cell rounding and inhibition of protein secretion when either transfected or delivered by the MARTX toxin (Kim and Satchell, 2016) . DmX cytopathic effects are dependent on autoprocessing as DmX catalytic cysteine mutants do not induce Golgi dispersion and simply localize to an intact Golgi. Co-immunoprecipitation studies indicate DmX binds to Golgi associated ARFs, which induce the effectors autoprocessing function (Kim and Satchell, 2016) . However, whether DmX directly modifies Golgi ARFs or only utilizes them as a eukaryotic specific activating factor is still under investigation.
Other effector domains
The mechanism and function of three out of the ten known effector domains still remain elusive. Of these three effector domains, the domain of unknown function in the first position (DUF1) is the best characterized. DUF1 (also known as RTX-D) was found to bind to prohibitin 1 (PHB1) in a yeast-2 hybrid screen. PHB1 protein levels were found to increase in a toxin dependent manner and treatment of HeLa cells with an anti-PHB1 antibody inhibits toxin dependent cytopathicity . Therefore, the PHB1-DUF1 interaction might promote toxin translocation. However, as not all MARTX toxins have DUF1 in their domain repertoire, this interaction needs to be further explored.
Two additional effectors have yet to be studied. The vegetative insecticidal 2 homology domain (VIP2) effector is predicted by homology to have ADP-ribosylating activity, while the Photorhabdus asymbiotica homology domain 2 (PasyHD2) effector is predicted by homology to localize to lipid rafts (French et al., 2009; Satchell, 2011) .
MARTX toxin effector synergy and crosstalk?
Much of the biochemical and cell biological characterization of MARTX effectors has focused on studies of effectors individually. However, the activity of the holotoxin might not simply be a sum of its parts, but might vary in its overall activity between strains depending on effector combinations (Fig. 3) . Indeed, effector 'crosstalk' may contribute to why bacterial strains with different effector combinations have differences in virulence (Kwak et al., 2011; Kim et al., 2017; Murciano et al., 2017) . Effector crosstalk has already been directly demonstrated in the MARTX toxin of V. cholerae. When ABH is delivered independently of RID and ACD, not only does it inhibit autophagy but it also activates the small GTPase CDC42 (Agarwal et al., 2015b; Dolores et al., 2015) . However, CDC42 activation is inhibited when ABH is delivered in the context of a wild-type holotoxin that also contains RID, which suppresses CDC42 activation (Dolores et al., 2015) . The net result in cells treated with holotoxin ranges from no change to a slight decrease in active (GTP-bound) CDC42. Activation of CDC42 by other bacterial effectors, such as SopE, induce the A. Previously identified interaction between RID and ABH. ABH mediated cleavage and subsequent depletion of PI3P disrupts lipid homeostasis in the cell leading to downstream activation of CDC42. However, CDC42 activation is inhibited in the presence of RID. B. Hypothetical interaction between MCF, ABH and DUF1. ABH could exacerbate MCF-mediated apoptosis by inhibiting clearance of damaged mitochondria. However, DUF1 could additionally increase host resistant to apoptosis by upregulating cellular prohibitin 1. C. Potential interaction between ACD, RID and ExoY. Both RID and ACD could promote ExoY activation by depolymerizing the actin cytoskeleton and increase cellular G-actin. ACD could either further activate or inhibit ExoY activity by cross-linking G-actin.
production of pro-inflammatory cytokines through NOD1 and NF-jB (Keestra et al., 2013) . Thus, ABH mediated activation of CDC42 could induce an innate immune response or activate other signaling pathways that might be detrimental to the bacteria and co-delivery of RID with ABH inhibits that response.
While bi-directional regulation of CDC42 is thus far the only demonstrated instance of crosstalk, the function of many effectors overlap or synergize. Indeed, effector interplay between DUF1, RID, MCF and RRSP and the impact on protein phosphorylation has recent been investigated. The V. vulnificus holotoxin was found to inhibit phosphorylation of Src family kinases, focal adhesion kinase, proline-rich tyrosine kinase 2 (Pyk2), phosphoinositide 3-kinase (PI3K) and Akt. Deletion of any one effector had no impact on the inhibition, although combinations of deletions, such as DUF1 or RID in combination with MCF and RRSP, led to a significant restoration of phosphorylation of these proteins (Chen et al., 2017) . Similarly, although RRSP is sufficient to inactivate ERK phosphorylation, deletion of the effector domain from the MARTX toxin of V. vulnificus does not alleviate MARTX toxin dependent ERK inactivation (Antic et al., 2015) . Therefore, other MARTX toxin effector domain may also target ERK signaling.
These are demonstrated examples of how effectors may be synergistic or antagonistic suggesting the possibility of more crosstalk events. ABH, MCF and DUF1 could result in variation on induction of apoptosis. Damaged mitochondria are normally cleared from the cell through autophagic pathways (Hammerling et al., 2017) . However, ABH could inhibit clearance of mitochondria damaged by MCF by inhibiting autophagy and thereby possibly exacerbate MCF-mediated cytopathicity. Furthermore, knockdown of PHB1 under autophagyinhibiting conditions has been shown to significantly increase intestinal epithelial cell susceptibility to mitochondrial damage (Kathiria et al., 2012) . Therefore, ABH could enhance MCF-mediated cytopathicity. However, when all three effectors are present together, as is found in the most common isolates of V. vulnificus and in Xenorhaddus bovienii (Satchell, 2011) , DUF1 could inhibit that enhancement by upregulating PHB1, thus making the cells more resistant to mitochondrialmediated cell death.
Another possible interplay is likely between ACD and ExoY. ACD mediated cross-linking of the actin cytoskeleton stimulates rapid actin depolymerization that would at least transiently create larger pools of monomeric G-actin to stimulate ExoY adenylate cyclase activity. More so, future studies will need to be done to determine if ExoY can utilize cross-linked actin as an activator in cells affected by toxins where both ExoY and ACD are found, such as in V. vulnificus strain E64MW (Ziolo et al., 2014) . Alternatively, if cross-linked actin is not able to bind and stimulate the ExoY-like effector domain, then co-present ACD would ultimately limit ExoY activity after all the actin is successfully cross-linked. RID-mediated actin depolymerization could likewise stimulate ExoY activity in strains such as V. vulnificus BT3, V. carribenthicus or V. nigripulchritudo where both effector domains are present (Le Roux et al., 2011; Ziolo et al., 2014) A final strategy for differential toxin interplay can be related to strategies for toxin delivery. CPD-mediated separation of the effector domains from the holotoxin is surprisingly not always required for effector function. The processing event significantly increases activity of some effectors targeting cytosolic proteins, while having less effect on the function of effectors that target membranelocalized proteins (Kudryashov et al., 2008a; Dolores et al., 2015) . Furthermore, some effectors require protein co-factors or to be targeted to specific organelles for activation, which would require intracellular trafficking (Kim and Satchell, 2016) . Therefore, effectors targeting plasma membrane proteins can immediately act on their substrates, while other effectors are sequestered away from their substrates until they are released from the holotoxin by CPD and can traffic to the site of action. This may be an additional mechanism by which the MARTX toxins temporally coordinate multiple toxin activities.
Impact of effector domain composition on virulence
This impact of different sets of co-present effector domains is likely to have major consequences for virulence, although studies of this type are just beginning. Notably, removal of the RRSP domain that cleaves Ras dramatically reduces virulence of V. vulnificus strain CMCP6, while removal of MCF did not dramatically affect virulence (Kwak et al., 2011; Gavin and Satchell, 2017) . By contrast, completely swapping MCF and RRSP in place of ExoY and DmX in the BT3 V. vulnificus strain to match its putative progenitor strain dramatically increased virulence (Kim et al., 2017) . Finally, a recent study found that the collection of certain effector domains could induce the expression of pro-inflammatory genes, while another strain with a different set of effectors can downregulate many pro-inflammatory genes (Murciano et al., 2017) .
Conclusions and future perspectives
This review covers the current understanding of toxin structure, mechanisms of effector autoprocessing and effector function. Mechanisms of pore formation are not discussed in depth because there is still a limited understanding of how the pore is formed and how it subsequently translocates effector domain regions of varying sizes. This highlights the need to explore areas such as how the MARTX toxin binds to the host cell and how the repeat regions are inserted in the membrane to form the pore. These studies may include identifying host cell receptors, along with identifying if a single toxin is sufficient to form a pore or determine if multiple copies are required to form a large enough channel for effector delivery. This future work may also require methods to purify the full-length MARTX toxin. This has been a challenge in the field due to the size of the toxins. Purifying the protein and identifying the structure of the repeat regions may provide valuable insight into how the pore is formed.
Additionally, as more is discovered about the function of the effector domains, future work will have to delve into how these effectors function together to promote virulence. As observed in V. vulnificus, strains containing different MARTX toxin effector repertories have different virulence potential (Kwak et al., 2011; Kim et al., 2017; Murciano et al., 2017) . While this could be the result of each effector having different effects on cell function or gene expression with the holotoxin adding up by the sum of its parts, it may not be that simple. Instead, the consequences of each effector function may regulate each other either to enhance or temper overall cytotoxic, cytopathic, pro-inflammatory or anti-inflammatory responses. In this model, each effector does not alone contribute to virulence, but instead, either promotes or inhibits virulence depending on other co-delivered effectors. Identifying the mechanisms by which effectors crosstalk and how these regulate virulence will not only lead to understanding what effector combinations are more virulent but also give insight into how the host responds to different cytopathic functions and how these responses are further regulated to promote bacterial pathogenesis.
